Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Mylan Inc    MYL   US6285301072

MYLAN INC (MYL)

49
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/17/2014 07/18/2014 07/21/2014 07/22/2014 07/23/2014 Date
51.43(c) 51.9(c) 51.39(c) 52.06(c) 52.34(c) Last
4 853 636 3 660 112 2 852 265 3 493 149 5 775 187 Volume
-0.39% +0.91% -0.98% +1.30% +0.54% Change
More quotes
Company
Mylan, Inc. is a generic and specialty pharmaceuticals company, through its subsidiaries, which develops, manufactures, markets and distributes pharmaceuticals. The company operates its business through two segments: Generics & Specialty. The Generics segment primarily develops, manufactures, sells... 
Sector
Pharmaceuticals
Calendar
08/07Earnings Release
Surperformance© rating of Mylan Inc
Trading Rating : Investor Rating :
More about the company
Chart MYLAN INC
Duration : Period :
Mylan Inc Technical Analysis Chart | MYL | US6285301072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 7 773 M
EBIT 2014 2 019 M
Net income 2014 1 112 M
Debt 2014 6 063 M
Yield 2014 -
Sales 2015 8 853 M
EBIT 2015 2 446 M
Net income 2015 1 450 M
Debt 2015 4 729 M
Yield 2015 -
PER 2014 19,74
PER 2015 14,88
EV / Sales 2014 3,30x
EV / Sales 2015 2,74x
Capitalization 19 561 M
More Financials
Latest news on MYLAN INC
1d ago MYLAN : Patent Issued for Stabilized Tolterodine Tartrate Formulations
1d ago MYLAN : To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Gen..
1d ago MYLAN : Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Ap..
1d ago MYLAN : Wins Motion for Temporary Restraining Order Against Apotex for Authorize..
2d ago EXCLUSIVE - INDIA'S LUPIN, U.S. FIRM : sources
2d ago India's Lupin, U.S. firms weigh bids for GSK's mature drugs -sources
5d agoDJRoche Not Interested in Large Acquisitions, Says CEO -- Report
6d ago MYLAN : More Tax Inversions: Abbott Selling Part of Generic Drug Business to Myl..
7d ago MYLAN : Says It Wins Motion To Enjoin GSK From Providing Paroxetine CR To Apotex
7d ago MYLAN : Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Ap..
07/16 MYLAN : Launches Generic Micardis® Tablets
07/16 Sanofi held talks with Abbott, Mylan about mature drugs - document
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Technical analysis
Income Statement Evolution
Mylan Inc : Income Statement Evolution
More Financials
EPS Revisions
Mylan Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF